Discover how a leading pharmaceutical manufacturer achieved significant improvements in new patient starts and long-term adherence for MDD treatment.

In a competitive market, driving medication adherence can be a challenge.

This success story reveals the targeted campaign strategy that led to:

• >1,800 incremental TRx for both first fill and refill programs.
• 2.4% absolute incremental NRx lift.
• 70%+ patient engagement.

Learn how timely, personalized support, including copay assistance and refill reminders, can transform your patient outcomes.

Unlock the Secrets to a 2.4% NRx Lift and 70%+ Patient Engagement